nine uremic patients on maintenance hemodialysis who showed wide arterial and/or stable periarticular calcifications in spite of a well controlled hyperphosphatemia were treated with the diphosphonate disodium ethane-1-hydroxy-1,1-diphosphonate ( ehdp ) in doses of 7.5 to 10 mg/kg of body wt/per day for 5 to 9 months .
C0012544
diphosphonate
C0086268
ehdp